MIRA INFORM REPORT

 

 

Report Date :

20.08.2014

 

IDENTIFICATION DETAILS

 

Name :

MEDICAL ASSOCIATION EIKOKAI

 

 

Registered Office :

1-2-30 Seiji Sugitomachi Kita-Katsushikagun Saitama-Pref 345-0025         

 

 

Country :

Japan

 

 

Financials (as on) :

31.03.2013

 

 

Date of Incorporation :

December, 1989

 

 

Com. Reg. No.:

0300-05-007485

 

 

Legal Form :

Medical Association (Iryo Hojin)

 

 

Line of Business :

Subject company is a medical association operating 8 clinics in Tokyo, Saitama and Kanagawa for general clinic treatment.

 

 

No of Employees :

30

 

RATING & COMMENTS

 

MIRA’s Rating :

Ba

 

RATING

STATUS

PROPOSED CREDIT LINE

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

Satisfactory

 

Status :

Satisfactory

 

 

Payment Behaviour :

No Complaints

 

 

Litigation :

Clear

 

NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

ECGC Country Risk Classification List – June 01, 2014

 

Country Name

Previous Rating

(31.03.2014)

Current Rating

(01.06.2014)

Japan

A1

A1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low Risk

 

A2

Moderate Low Risk

 

B1

Moderate Risk

 

B2

Moderate High Risk

 

C1

High Risk

 

C2

Very High Risk

 

D

 

JAPAN - ECONOMIC OVERVIEW

 

In the years following World War II, government-industry cooperation, a strong work ethic, mastery of high technology, and a comparatively small defense allocation (1% of GDP) helped Japan develop a technologically advanced economy. Two notable characteristics of the post-war economy were the close interlocking structures of manufacturers, suppliers, and distributors, known as keiretsu, and the guarantee of lifetime employment for a substantial portion of the urban labor force. Both features are now eroding under the dual pressures of global competition and domestic demographic change. Japan's industrial sector is heavily dependent on imported raw materials and fuels. A small agricultural sector is highly subsidized and protected, with crop yields among the highest in the world. While self-sufficient in rice production, Japan imports about 60% of its food on a caloric basis. For three decades, overall real economic growth had been spectacular - a 10% average in the 1960s, a 5% average in the 1970s, and a 4% average in the 1980s. Growth slowed markedly in the 1990s, averaging just 1.7%, largely because of the after effects of inefficient investment and an asset price bubble in the late 1980s that required a protracted period of time for firms to reduce excess debt, capital, and labor. Modest economic growth continued after 2000, but the economy has fallen into recession three times since 2008. A sharp downturn in business investment and global demand for Japan's exports in late 2008 pushed Japan into recession. Government stimulus spending helped the economy recover in late 2009 and 2010, but the economy contracted again in 2011 as the massive 9.0 magnitude earthquake and the ensuing tsunami in March disrupted manufacturing. The economy has largely recovered in the two years since the disaster, but reconstruction in the Tohoku region has been uneven. Prime Minister Shinzo ABE has declared the economy his government's top priority; he has overturned his predecessor's plan to permanently close nuclear power plants and is pursuing an economic revitalization agenda of fiscal stimulus, monetary easing, and structural reform. Japan joined the Trans Pacific Partnership negotiations in 2013, a pact that would open Japan's economy to increased foreign competition and create new export opportunities for Japanese businesses. Measured on a purchasing power parity (PPP) basis that adjusts for price differences, Japan in 2013 stood as the fourth-largest economy in the world after second-place China, which surpassed Japan in 2001, and third-place India, which edged out Japan in 2012. The new government will continue a longstanding debate on restructuring the economy and reining in Japan's huge government debt, which is exceeding 230% of GDP. To help raise government revenue and reduce public debt, Japan decided in 2013 to gradually increase the consumption tax to a total of 10% by the year 2015. Japan is making progress on ending deflation due to a weaker yen and higher energy costs, but reliance on exports to drive growth and an aging, shrinking population pose other major long-term challenges for the economy.

 

Source : CIA

 

COMPANY NAME & ADDRESS

 

MEDICAL ASSOCIATION EIKOKAI

 

REGD NAME:    Medical Association Eikokai

MAIN OFFICE:  1-2-30 Seiji Sugitomachi Kita-Katsushikagun Saitama-Pref 345-0025 JAPAN

Tel: 0480-33-2464     

 

                        *.. The address and other details given are those of Ebina Clinic in

                        Kanagawa-Pref

 

URL:                 http://www.eikokai.or.jp

E-Mail address: (thru the URL)

 

 

ACTIVITIES

 

Operation of clinics

 

 

BRANCHES

 

Kanagawa (4), Tokyo (2), Saitama (2).  (--Clinics)

Ebina Clinic: Ebina Century Plaza 5F, 2-1-16 Chuo Ebina Kanagawa-Pref;

Phone: 046-235-0290; Fax: 046-235-0675

Artificial dialysis

 

 

OFFICERS

 

TERUAKI TAMAI, PRES & CEO

                       

Yen Amount:     In million Yen, unless otherwise stated

 

 

SUMMARY

 

FINANCES        FAIR                             A/SALES          Yen 150 M

PAYMENTS      NO COMPLAINTS          CAPITAL           Yen 32 M

TREND STEADY                       WORTH            Yen 284 M       

STARTED         1989                             EMPLOYES      30

 

 

COMMENT

 

OPERATOR OF CLINICS (MEDICAL ASSOCIATION).

FINANCIAL SITUATION CONSIDERED FAIR AND GOOD FOR ORDINARY

BUSINESS ENGAGEMENTS.

                       

 

HIGHLIGHTS

           

The subject company is a medical association operating 8 clinics in Tokyo, Saitama and Kanagawa for general clinic treatment.  The Ebina Clinic is specialized treatment for artificial dialysis. 

 

 

FINANCIAL INFORMATION

           

Financials are only partially disclosed.  Clinics are individually disclosing financials.

 

The sales volume for Mar/2013 fiscal term amounted to Yen 150 million, a similar amount in the previous term.  The net profit marked time at Yen 15 million, similarly in the previous term.

 

For the term that ended Mar 2014 the net profit was projected at Yen 17 million, on a 7% rise in turnover, to Yen 160 million.  Final results are yet to be released.

 

The financial situation is considered FAIR and good for ORDINARY business engagements. 

 

 

REGISTRATION

 

Date Registered:                                  Dec 1989

Regd No.:                                             0300-05-007485 (Saitama-Kita-Katsushikagun)

Legal Status:                           Medical Association (Iryo Hojin)

Authorized:                              2,600 shares

Issued:                                     651 shares

Sum:                                        Yen 32.6 million

Major shareholders (%):                       Teruaki Tamai, others (--100)

     No. of shareholders:                       7

 

Nothing detrimental is known as to the commercial morality of executives.

 

 

OPERATION

           

Activities: Medical association operating 8 clinics in Tokyo, Kanagawa and Saitama (--100%)

 

Clients: Patients, others 

No. of accounts: Unavailable

Domestic areas of activities: Centered in the greater-Tokyo

Suppliers: Medical institutions, pharmaceutical makers, municipal offices, other

 

Payment record: No Complaints

 

Location: Business area in Saitama.  Office premises at the caption address are leased and maintained satisfactory.

 

Bank References:

Local Bank Saitama & Tokyo)

Relations: Satisfactory

 

 

FINANCES

 

 (In Million Yen)

Terms Ending:

　

31/03/2014

31/03/2013

31/03/2012

31/03/2011

Annual Sales

　

160

150

150

132

Recur. Profit

　

..

..

..

..

Net Profit

　

17

15

15

16

Total Assets

　

　

N/A

N/A

N/A

Net Worth

　

　

284

269

254

Capital, Paid-Up

　

　

32

32

32

Div.P.Share(¥)

　

　

0.00

0.00

0.00

<Analytical Data>

　

(%)

(%)

(%)

(%)

    S.Growth Rate

　

6.67

0.00

13.64

3.94

    Current Ratio

　

　

..

..

..

    N.Worth Ratio

　

　

..

..

..

    N.Profit/Sales

　

10.63

10.00

10.00

12.12

Notes: Financials are only partially disclosed.

Forecast (or estimated) figures for the 31/03/2014 fiscal term.

 

 

FOREIGN EXCHANGE RATES

 

Currency
Unit

Indian Rupees

US Dollar

1

Rs.60.73

UK Pound

1

Rs.101.48

Euro

1

Rs.81.04

 

 

INFORMATION DETAILS

 

Analysis Done by :

RAS

 

 

Report Prepared by :

SMN

 

 

RATING EXPLANATIONS

 

RATING

STATUS

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

Credit not recommended

--

NB

                                       New Business

--

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                 Payment record (10%)

Credit history (10%)                    Market trend (10%)                                Operational size (10%)

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.